BMD
IGC icon

Better Money Decisions’s IGC Pharma IGC Stock Holding History

Better Money Decisions’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-425
Closed -$1K – 298
2021
Q3 		$1K Hold
425
– – ﹤0.01% 625
2021
Q2 		$1K Hold
425
– – ﹤0.01% 611
2021
Q1 		$1K Buy
+425
New +$772 ﹤0.01% 562

Other funds holding IGC

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Better Money Decisions's IGC Position: Q4 2021 in Review

Better Money Decisions sold out of IGC Pharma (IGC) in Q4 2021, closing a stake of 425 shares — an estimated $1K sold.

Better Money Decisions first reported a position in IGC in Q1 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 29 funds tracked by Wall St. Rank hold IGC as of Q4 2021.

  • Better Money Decisions reported no remaining IGC Pharma position as of Q4 2021 after selling out during the quarter.
  • Better Money Decisions sold 425 IGC Pharma shares in Q4 2021, an estimated $1K.
  • Better Money Decisions first reported a position in IGC Pharma in Q1 2021 and held it in 3 quarters.
  • Better Money Decisions's IGC Pharma position peaked at $1K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2021.

Based on Better Money Decisions's 13F filing for Q4 2021, filed 14 Feb 2022.